Guidant Considers CRT Coverage Strategy After Study Shows Mortality Benefit

Guidant plans to accelerate talks with CMS in late 2004 as it gauges whether to pursue a Medicare national coverage decision for cardiac resynchronization therapy (CRT) devices

More from Archive

More from Medtech Insight